Order Article Reprints

Zhuang X, Martin TA, Ruge F, Zeng J, Li X, Khan E, Dou Q, Davies E, Jiang WG. Expression of Claudin-9 (CLDN9) in Breast Cancer, the Clinical Significance in Connection with Its Subcoat Anchorage Proteins ZO-1 and ZO-3 and Impact on Drug Resistance. Biomedicines. 2023; 11(12):3136. https://doi.org/10.3390/biomedicines11123136

Zhuang, Xinguo, Tracey A. Martin, Fiona Ruge, Jianyuan (Jimmy) Zeng, Xinyu (Amber) Li, Elyas Khan, Qingping Dou, Eleri Davies, and Wen G. Jiang. 2023. "Expression of Claudin-9 (CLDN9) in Breast Cancer, the Clinical Significance in Connection with Its Subcoat Anchorage Proteins ZO-1 and ZO-3 and Impact on Drug Resistance" Biomedicines 11, no. 12: 3136. https://doi.org/10.3390/biomedicines11123136

Zhuang, X., Martin, T. A., Ruge, F., Zeng, J., Li, X., Khan, E., Dou, Q., Davies, E., & Jiang, W. G. (2023). Expression of Claudin-9 (CLDN9) in Breast Cancer, the Clinical Significance in Connection with Its Subcoat Anchorage Proteins ZO-1 and ZO-3 and Impact on Drug Resistance. Biomedicines, 11(12), 3136. https://doi.org/10.3390/biomedicines11123136